John H Heiligenstein

Summary

Country: USA

Publications

  1. ncbi request reprint Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study
    John H Heiligenstein
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    J Child Adolesc Psychopharmacol 16:207-17. 2006
  2. ncbi request reprint Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents
    Mary Nilsson
    Eli Lilly and Company, Indianapolis, IN 46285, USA
    J Child Adolesc Psychopharmacol 14:412-7. 2004
  3. ncbi request reprint Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial
    Graham J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, USA
    J Am Acad Child Adolesc Psychiatry 41:1205-15. 2002
  4. ncbi request reprint Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study
    Graham J Emslie
    University of Texas Southwestern Medical Center at Dallas, Texas, USA
    J Am Acad Child Adolesc Psychiatry 43:1397-405. 2004

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study
    John H Heiligenstein
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    J Child Adolesc Psychopharmacol 16:207-17. 2006
    ....
  2. ncbi request reprint Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents
    Mary Nilsson
    Eli Lilly and Company, Indianapolis, IN 46285, USA
    J Child Adolesc Psychopharmacol 14:412-7. 2004
    ..The aim of this study was to assess the safety of subchronic fluoxetine treatment for major depressive disorder (MDD) in children and adolescents...
  3. ncbi request reprint Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial
    Graham J Emslie
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, USA
    J Am Acad Child Adolesc Psychiatry 41:1205-15. 2002
    ..This report presents results from the acute treatment phase of a clinical trial designed to confirm efficacy of a fixed dose of 20 mg of fluoxetine in children and adolescents with major depressive disorder (MDD)...
  4. ncbi request reprint Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study
    Graham J Emslie
    University of Texas Southwestern Medical Center at Dallas, Texas, USA
    J Am Acad Child Adolesc Psychiatry 43:1397-405. 2004
    ....